Pertaining health needs and accelerating technological development put an ever-increasing demand on limited health budgets. Important decisions have to be made on the use of public funds. Multicriteria decision analysis (MCDA) may be consider as a good method for making these choice. Do you use this method in your hospital? If so, what is your experience with it?
No in my country, MCDA only for the equippment (Hospital based HTA).
Ciao
Davide
I have a PhD student, just finalizing his thesis on MCDA for rare diseases therapies:
• Iskrov G, Jessop E, Miteva-Katrandzhieva T, Stefanov R. Budget impact of rare diseases: proposal for a theoretical framework based on evidence from Bulgaria. Georgian Med News. 2015 May;(242):46-53.
• Iskrov G, Stefanov R. Prospects of risk-sharing agreements for innovative therapies in a context of deficit spending in Bulgaria. Front. Public Health 3:64.
• Iskrov G, Stefanov R. Post-marketing access to orphan drugs: a critical analysis of health technology assessment and reimbursement decision-making considerations. Orphan Drugs: Research and Reviews 2014, 4:1-9.
• Iskrov G, Raycheva R, Stefanov R. Insight into reimbursement decision-making criteria in Bulgaria: implications for orphan drugs. Folia Med (Plovdiv). 2013;55(3&4):80-86.